Home › Colon Cancer › NCT04751448

COLON-MD: Colon Cancer Longitudinal Study

COLON MD: Colon Cancer Longitudinal Study of the Microbial Metabolites and Dietary Factors That Influence Response to Treatment

Who can join

Ages 18 to 79 · All sexes

Inclusion Criteria:

* Colon cancer diagnosis
* Age \>18 and \< or equal to 79.
* Ability to perform informed consent
* FOLFOX treatment expected

Exclusion Criteria:

* Not Pregnant
* Does not have Lynch syndrome or FAP diagnosis.
* Inability to perform inform consent
* inability to comply with follow up program
* history of prior colon cancer diagnosis
* previous treatment with antibiotics in the last month.
* previous bowel resection.

About the study

The goal of this proposal is to identify how the composition of the gut microbiome and diet interact to impact chemotherapy-induced diarrhea incidence and severity.

Sponsor: Baylor Research Institute · Participants: 11 · Started: Feb 1, 2021

Contact the study team

Official record on ClinicalTrials.gov — NCT04751448

Locations in the U.S.

Conditions

• Colon Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.